Schivo's Strategic Acquisition of Mecaplast SA Enhances Manufacturing Expertise

Schivo Acquires Mecaplast SA: A Major Step Forward in Precision Manufacturing

In a significant industry move, Schivo, a prominent player in the MedTech sector, has officially announced its acquisition of Mecaplast SA, a highly specialized Swiss manufacturer known for its precision plastics, metals, and ceramics. This strategic acquisition aims to bolster Schivo's capabilities in injection molding and further establish the company as a trusted partner in the medical technology and life sciences fields.

Founded in 1971 and located in Botterens, Switzerland, Mecaplast has built a solid reputation for its technical excellence and quality in producing essential components and precision molds. Their facilities, certified under ISO 13485, span over 64,000 square feet and are equipped for micromolding, overmolding, injection molding, and cleanroom assembly. They serve some of the leading original equipment manufacturers (OEMs) in the medical technology and life sciences segments.

Graham Reeves, CEO of Schivo, expressed enthusiasm about the acquisition, stating, "Mecaplast brings decades of deep expertise in complex plastics, metals, and ceramics, aligning perfectly with our vision to create a global platform with diverse capabilities for advanced medical and life sciences devices. This collaboration enhances our ability to offer integrated solutions across multiple markets."

The acquisition also simplifies Schivo's vertical integration by incorporating plastic, metal, and ceramic manufacturing along with enhanced assembly and value-added services. With this newfound capacity, Schivo will establish a new European center of excellence that will facilitate advanced injection molding for plastics and metals, enhancing support for OEMs catering to the international MedTech and life sciences markets.

Jean-Marc Jaccottet, the CEO and owner of Mecaplast, shared his perspective on the merger, viewing it as an exciting evolution for the company. "Joining Schivo represents a natural progression for Mecaplast SA. Our team is eager to continue serving our existing clients while addressing the necessities of new ones. This alliance accelerates investment and development, leveraging our combined expertise to broaden the impact of our skills in precision injection molding and pioneering manufacturing."

As part of this integration, Mecaplast's facilities will function as Schivo's Global Center of Excellence for plastic, metal, and ceramic precision molding. Jaccottet will step into a leadership role in Schivo, taking charge of the Molding Technologies division and spearheading research and development initiatives. His leadership is expected to amplify the group’s capabilities and position Schivo as a key player in advanced molding solutions.

Schivo has earned its reputation by contributing to the development of future medical devices and life sciences technologies. Collaborating with industry leaders, Schivo designs, manufactures, assembles, and delivers prototypes and finished devices swiftly to assist clients in bringing their innovations to market. Their approach addresses unique engineering challenges and streamlines the supply chain, supporting customers throughout stages of product development and commercial launch.

In conclusion, Schivo's acquisition of Mecaplast marks a pivotal moment in the MedTech industry, reinforcing the company's commitment to excellence and innovation. With expanded capabilities and a broader expertise pool at their disposal, Schivo is poised to make a significant impact on the future of medical technology and life sciences. For more information, visit www.schivomedical.com.